Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Madhukar Trivedi, MD
University of Texas Southwestern Medical Center
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Ucla Vine Street Clinic
Los Angeles, California, United States
- Center on Substance Use and Health (csuh)
San Francisco, California, United States
- Cove Behavioral Health
Tampa, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- University of Illinois at Chicago
Chicago, Illinois, United States
- Mountain Manor Treatment Center
Baltimore, Maryland, United States
- Berman Center for Outcomes and Clinical Research at Hennepin Healthcare
Minneapolis, Minnesota, United States
- Addictions Institute of Mount Sinai
New York, New York, United States
- Utsw Medical Center, Center for Depression Research and Clinical Care
Dallas, Texas, United States
- University of Texas Health San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Apr 2023
- Primary completion
- 27 Jun 2025
- Completion
- 21 Jul 2025
- Last update posted
- 21 Oct 2025
- Registered enrollment
- 427
- Registry id
- NCT05262270
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.